Healthcare · Biotechnology
Is Lunai Bioworks Inc. (LNAI) Stock Halal?
Shariah Compliance Across 5 Standards — Live
Shariah Compliance Verdict — 5 Standards
AAOIFI (Shari'ah Standard 21)market-cap basis
debt/MC 46.6% > 30%; impure income 100.0% > 5%
Dow Jones Islamic Marketmarket-cap basis
impure income 100.0% > 5%
FTSE Shariah (Yasaar)total-assets basis
debt/assets 66.2% > 33%; impure income 100.0% > 5%
MSCI Islamictotal-assets basis
debt/assets 66.2% > 33%; impure income 100.0% > 5%
S&P Shariahmarket-cap basis
impure income 100.0% > 5%
Live verdicts from the Halal Terminal screening engine, recomputed against the issuer's latest filings.
Plain-English Summary
Fails AAOIFI, DJIM, FTSE, MSCI, S&P on debt/MC 46.6% > AAOIFI 30%, DJIM 33%, S&P 33%; interest/revenue 100.0% > AAOIFI 5%, DJIM 5%, FTSE 5%, MSCI 5%, S&P 5%; debt/assets 66.2% > FTSE 33%, MSCI 33%.
Business Activity Screen
Business activity is compliant.
Financial Ratios
Interest-bearing debt / market cap
AAOIFI ≤30% · DJIM/S&P <33% (trailing-avg MC)
46.6%
Cash & interest-bearing / market cap
AAOIFI ≤30% of market cap
22.5%
Debt / total assets
FTSE/MSCI <33.33% of total assets
66.2%
Cash & interest-bearing / total assets
FTSE/MSCI <33.33% of total assets
32.0%
Receivables + cash / total assets
FTSE <50% · MSCI ≤70%
41.8%
Interest income / revenue
≤5% across all methodologies
100.0%
Raw ratios from the latest filings — each methodology applies its own basis and thresholds (see the verdict box above for per-standard outcomes).
Balance-Sheet Trajectory (8 Quarters)
| Quarter end | Debt / assets | Cash / assets | Receivables + cash / assets |
|---|---|---|---|
| 2024-06-30 | 0.8% | 0.1% | 0.1% |
| 2024-09-30 | 1.0% | 0.2% | 0.2% |
| 2024-12-31 | 1.1% | 0.3% | 0.3% |
| 2025-03-31 | 0.9% | 0.8% | 1.6% |
| 2025-06-30 | 9.0% | 1.1% | 1.1% |
| 2025-09-30 | 8.0% | 9.0% | 9.0% |
| 2025-12-31 | 7.3% | 7.4% | 7.4% |
| 2026-03-31 | 4.3% | 32.0% | 32.0% |
A stock that has screened comfortably for eight straight quarters is a different story from one that crossed a threshold last quarter — trajectory shows which one this is.
Compliance Watch
2026-05-01 · verdict-relevant (m and a)
Frequently Asked Questions
Is Lunai Bioworks Inc. (LNAI) halal to invest in?
Lunai Bioworks Inc. currently screens as non-compliant on the Halal Terminal engine. The verdict is recomputed against the issuer's latest financial filings and all five major methodologies (AAOIFI, DJIM, FTSE, MSCI, S&P) — see the per-standard breakdown above. This is a data-driven application of published standards, not a fatwa.
Is LNAI compliant under AAOIFI?
No — LNAI currently fails AAOIFI screening: debt/MC 46.6% > 30%; impure income 100.0% > 5%.
Do I need to purify dividends from LNAI?
A purification rate could not be computed from the latest filings; consult the methodology page for how purification works.
Why do halal screening apps disagree about LNAI?
Different services apply different ratio bases (market capitalization vs total assets), different revenue classifications, and different data vintages. This page shows both AAOIFI readings side by side and classifies revenue segments explicitly so the source of any disagreement is visible.
Related Healthcare Stocks
All Healthcare →Hims & Hers Health, Inc.
Healthcare
Johnson & Johnson
Healthcare
Pfizer Inc.
Healthcare
Eli Lilly and Company
Healthcare
Intuitive Surgical, Inc.
Healthcare
Amgen Inc.
Healthcare
Abbott Laboratories
Healthcare
Profusa, Inc.
Healthcare
Screen Your Full Portfolio
Halal Terminal screens stocks and ETFs across 5 Shariah standards simultaneously — with live ratios, segment-level business income, purification calculations, and Zakat reports.
Disclaimer: This page is for educational and informational purposes only and does not constitute financial or religious advice. Verdicts and figures come from the Halal Terminal screening engine, computed from the issuer's public financial filings and refreshed regularly (last screened 2026-07-06). This is a data-driven application of published Shariah standards — not a fatwa. Consult a qualified Islamic finance scholar or advisor for personalised guidance.